The Hedge Book logo The Hedge Book Read smarter. Invest better.

AI Stock Monitor

CIPLA.NS - Cipla

Company-specific Hedge Book research coverage for Cipla, classified in Pharmaceuticals within Healthcare. Verified developments are interpreted through its sector, industry, and company-specific monitoring framework.

Public company · India · Healthcare · Pharmaceuticals

NSE · Healthcare · Research updated · Market data updated Research and source refreshes run four times daily. The timestamps above identify the latest successful research and market-data updates.
Hedge Score 50 /100
NeutralNeutral
Confidence55%
Community Bullish0%
Followers0
Current Price₹1,463.801D -0.9%

Price History

CIPLA.NS chart

1,663.601,545.801,428.001,310.201,192.40 Aug 2025Oct 2025Dec 2025Feb 2026Apr 2026Jun 2026Aug 2026 2025-08-11 1,504.802026-02-10 1,342.102026-08-07 1,463.80

AI-Assisted Chart Analysis

Cipla technical analysis

Calculated from verified chart history for the selected tenor; no news or fundamental assumptions are used.

Technical only
Trend

Constructive uptrend: the latest level is above the 50-period average and the 50-period average is above the 200-period average.

Momentum

RSI is 56, a neutral reading. Above 70 can signal extension; below 30 can signal exhaustion.

Support scenario

The first technical watch zone is 1,393.00. A break below 1,350.80 invalidates the near-term support setup.

Resistance scenario

The first resistance/watch zone is 1,477.00. A confirmed break above 1,477.00 supports continuation.

Risk

Annualized realized volatility is +21.3%. Maximum lookback drawdown is -28.3%, from a high-water mark of 1,663.60 to 1,192.40.

Potential levels are conditional chart scenarios, not personalized advice or instructions to buy or sell.

How To Read This Stock Brief
Hedge Score

Higher means the current research setup is stronger across signal, confidence, catalysts, risk balance, and market context. Lower means the setup is weaker or less supported.

Confidence

Higher confidence means the evidence is more consistent and relevant. It does not mean the stock has that percentage chance of going up.

Signal

Bullish, Bearish, or Neutral is the current AI research stance. It is designed to help you ask better questions, not to replace your decision process.

Community Bullish

This shows how signed-in users are voting. It is useful sentiment context, not proof that the crowd is right.

Read the full Hedge Score and confidence methodology

What Changed Today

  • Cipla has committed to a ₹200 crore investment in Karnataka, marking a new capital expenditure initiative within its domestic operations. This development coincides with persistent market reports citing ongoing pressure on the company's stock performance, primarily attributed to headwinds in the US market. While the investment signals a strategic focus on domestic capacity or infrastructure, the company has not disclosed specific timelines or the precise nature of the facilities involved.

Why It Matters

  • The ₹200 crore capital allocation represents a tangible commitment to domestic growth, potentially aimed at strengthening manufacturing or R&D capabilities to diversify the company's geographic revenue mix.
  • However, this expenditure does not immediately mitigate the near-term earnings headwinds stemming from US generic pricing and regulatory pressures, which remain the dominant factor influencing investor sentiment.
  • The market's muted reaction suggests that investors are prioritizing the resolution of US-specific competitive challenges over long-term domestic infrastructure spending.

AI Opinion

  • Read: The current evidence-grounded AI read is neutral.
  • Evidence: The Karnataka investment is a positive signal for long-term domestic capacity, yet it remains secondary to the more immediate concerns regarding US market performance.
  • Uncertainty: While the company maintains a robust product pipeline, the persistent drag from US operations creates a valuation disconnect that capital expenditure alone cannot resolve.
  • Watch: Investors should monitor whether this domestic expansion can effectively improve margins or diversify revenue streams to offset international pricing pressures.

Key Risks

  • Execution Risk: The ₹200 crore investment may face delays or cost overruns, potentially impacting free cash flow and return on capital employed. This would be evidenced by a lack of progress updates or revisions to capital expenditure guidance in subsequent filings.
  • US Market Drag: Continued pricing pressure or regulatory hurdles in the US could overshadow domestic expansion efforts, leading to further earnings compression. This risk would be confirmed by negative commentary in future quarterly earnings reports regarding US generic sales or margin erosion.

Upcoming Catalysts

  • Operational Efficiency: Clearer communication regarding the specific purpose, expected return, and timeline of the ₹200 crore Karnataka investment could improve investor confidence in the company's domestic growth strategy and capital allocation discipline.
  • US Market Recovery: Evidence of stabilization in US generic pricing or the successful resolution of regulatory hurdles would likely serve as a significant catalyst, shifting investor focus back to the company's underlying product pipeline and growth potential.

Upcoming Events

7:00 AM CSTDaily monitor scheduled

The automated scan is configured to refresh the stock brief each morning.

Market hoursPrice and news watch

The monitor checks price action, company news, filings, sector read-throughs, and major macro drivers.

Next catalystEvent watch

Upcoming earnings, product, policy, and industry events are tracked for thesis-changing updates.

Hedge Score Drivers

  • Verified evidence is currently neutral across the covered research lanes.
  • Evidence currently covers sector and industry context, catalysts, risks, price and sentiment context.
  • Confidence is constrained by missing or incomplete evidence for earnings and financial trends, balance-sheet strength, company operating KPIs, valuation.

Last Updated

Sources and verification

Each generated research claim remains linked to its supporting update. Primary evidence comes from filings, company materials, or regulators; secondary evidence provides additional context.

  • Cipla to invest ₹200 crore; Rocket India ₹100 crore in Karnataka: Minister - manufacturing.economictimes.indiatimes.comSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Stocks in news: PB Fintech, LIC, Trent, Ola Electric, and Cipla - The Economic TimesSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla to invest Rs 200 crore in Karnataka - Deccan HeraldSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla to invest ₹200 crore in Karnataka; Rocket India announces ₹100 crore expansion - BusinessLineSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Stocks in the news: RIL, Ultratech, NTPC, IndiGo, Cipla, NDTV and fertilizers stocks - The Economic TimesSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline - The Economic TimesSecondary sourceReportedNews · Published 2026-07-27Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla to invest ₹200 crore in Karnataka; Rocket India announces ₹100 crore expansion - thehindubusinessline.comSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Stocks in news: Cipla, PC Jeweller, Shriram Finance, Grasim, Gland Pharma - economictimes.indiatimes.comSecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-09Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-08Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Upcoming CatalystSecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: Upcoming Catalysts
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-09Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-08Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Key Risks
  • The Hedge Book: Key RiskSecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: Key Risks
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-09Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-08Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: AI OpinionSecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: Company-Specific Research Updates
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-09Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-08Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: Why It MattersSecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-09Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-08Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-04Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • The Hedge Book: What Changed TodaySecondary sourceReportedNews · Published 2026-08-03Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla wins FDA nod for Advair generic - ET Pharma - Indiatimes - pharma.economictimes.indiatimes.comSecondary sourceReportedNews · Published 2026-08-02Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • CIPLA Share Price Today: Cipla NSE - TickertapeSecondary sourceReportedNews · Published 2026-08-01Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline - economictimes.indiatimes.comSecondary sourceReportedNews · Published 2026-08-01Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Stocks in news: PB Fintech, LIC, Trent, Ola Electric, and Cipla - economictimes.indiatimes.comSecondary sourceReportedNews · Published 2026-08-06Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla to invest Rs 200 crore in Karnataka - deccanherald.comSecondary sourceReportedNews · Published 2026-08-05Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS - Business StandardSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla Standalone June 2026 Net Sales at Rs 5,077.68 crore, up 0.62% Y-o-Y - Moneycontrol.comSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
  • Cipla Consolidated June 2026 Net Sales at Rs 7,119.28 crore, up 2.33% Y-o-Y - Moneycontrol.comSecondary sourceReportedNews · Published 2026-07-30Open verification sourceSupports: What Changed Today, Why It Matters, AI Opinion
Market-data attributionYahoo Finance delayed market data · provider detailsMarket prices are supporting signals only and do not establish the research conclusion.

Community View

Sign in with Google to vote once per stock.

Bullish
Bearish
Neutral

Total votes: 0

Disclaimer

The Hedge Book provides AI-assisted educational market research. It is not a registered investment adviser, broker, dealer, or financial planner. Content may contain errors and should be independently verified. Do not treat this page as personalized advice to buy, sell, or hold any security.